ANG Lifesciences India’s board has decided to invest in the equity shares of ANG Healthcare India. Therefore consequent to the acquisition of 100% Equity stake by the company, ANG Healthcare India will become Wholly-Owned Subsidiary Company of ANG Lifesciences India.
The acquisition will help company in its brand-building, domestic branding and direct marketing initiative for the purposes of staying close to the customer and to serve its vision of providing innovative and high quality products at affordable prices all across the country following ethical business practices. The company’s Board of Directors in their meeting held on November 23, 2021, has decided to the same.
ANG Lifesciences India, incorporated in the year 2006, started with the business of manufacturing and marketing of finished pharmaceutical formulation in a dosage form of Sterile Dry Powder Injection Vial.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1837.15 |
| Dr. Reddys Lab | 1271.55 |
| Cipla | 1353.85 |
| Zydus Lifesciences | 1070.90 |
| Lupin | 2351.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: